Insider Transactions in Q1 2025 at Adverum Biotechnologies, Inc. (ADVM)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
19,566
+0.71%
|
$78,264
$4.38 P/Share
|
|
Mar 27
2025
|
Braden Michael Leonard |
SELL
Open market or private purchase
|
Direct |
16,593
-10.48%
|
$82,965
$5.19 P/Share
|
|
Mar 26
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Direct |
20,407
+14.01%
|
$102,035
$5.04 P/Share
|
|
Mar 20
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
30,600
+1.11%
|
$153,000
$5.61 P/Share
|
|
Mar 19
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
25,000
+0.92%
|
$100,000
$4.94 P/Share
|
|
Mar 18
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
62,341
+1.16%
|
$249,364
$4.67 P/Share
|
|
Feb 28
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
85,068
+3.16%
|
$340,272
$4.6 P/Share
|
|
Feb 27
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
86,802
+3.33%
|
$347,208
$4.46 P/Share
|
|
Feb 26
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
164,886
+6.35%
|
$659,544
$4.01 P/Share
|
|
Feb 25
2025
|
Linda M Rubinstein CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,125
+29.6%
|
-
|
|
Feb 25
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+20.56%
|
-
|
|
Feb 25
2025
|
Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,125
+35.61%
|
-
|
|
Feb 25
2025
|
Rabia Gurses Ozden Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,125
+50.0%
|
-
|
|
Feb 25
2025
|
Peter Soparkar CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
13,125
+23.76%
|
-
|